On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

BioCryst

FunderResearch funding and supported work

BioCryst is a funder indexed in ScholarIQ from OpenAlex.

What is known about BioCryst?

ScholarIQrecord summary

American pharmaceutical company

How many works does BioCryst have?

ScholarIQindexed works

BioCryst has 563 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for BioCryst?

ScholarIQopenalex

The OpenAlex for BioCryst is on the source record.

What is the ROR of BioCryst?

ScholarIQror

The ROR for BioCryst is on the source record.

What are the most-cited papers on BioCryst?

ScholarIQmost cited works
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando C. Fervenza, Keisha L. Gibson, Richard J. Glassock, David Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Carla Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Ronco, Jan‐Stephan Sanders, Sanjeev Sethi, Yusuke Suzuki, Sydney Tang, Vladimı́r Tesař, Marina Vivarelli, Jack F.M. Wetzels, Lyubov Lytvyn, Jonathan C. Craig, David J. Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege
Kidney International. 2021804 CitationsOPEN ACCESS
What do clinical trials teach us about the pathophysiology of human IgA nephropathy?
Raghunandan Konda, Arun Rajasekaran, Dana V. Rizk
Nephrology Dialysis Transplantation. 20255 CitationsOPEN ACCESS
470M+ articles · 14-day free trial